{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:28:37Z","timestamp":1765438117624},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Approximately one third of all patients with cardiogenic shock suffer from acute kidney injury. Percutaneous coronary intervention, intra-aortic balloon pump, and continuous renal replacement therapy (CRRT) require effective antiplatelet therapy and anticoagulation, resulting in a high risk for platelet loss and bleeding events. The reversible platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban was investigated to preserve platelet number and activation in a prospective open-blinded endpoint evaluation study.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Forty patients with cardiogenic shock and acute kidney injury requiring CRRT were randomly assigned to two groups receiving unfractioned heparin (UFH) (n = 20) or a combined anticoagulation with UFH and tirofiban (n = 20). The primary endpoint was platelet loss during CRRT. Secondary endpoints were urea reduction, haemofilter life span, bleeding events, and necessity for platelet transfusions.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>In UFH-treated patients, the percentage of platelet-monocyte aggregates significantly increased (<jats:italic>P<\/jats:italic> &lt; 0.001) and consecutively platelet cell count significantly decreased (<jats:italic>P<\/jats:italic> &lt; 0.001). In contrast, combined treatment with UFH and tirofiban significantly decreased platelet-monocyte aggregates and platelet numbers (<jats:italic>P<\/jats:italic> &lt; 0.001).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>This pilot study provides evidence that the use of tirofiban in addition to UFH prevents platelet loss and preserves platelet function in patients with cardiogenic shock and acute kidney injury requiring CRRT. The pathophysiological inhibition of platelet aggregation and platelet-monocyte interaction appears to be causally involved.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc6998","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T18:14:22Z","timestamp":1221156862000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study"],"prefix":"10.1186","volume":"12","author":[{"given":"Andreas","family":"Link","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Girndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simina","family":"Selejan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranja","family":"Rbah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,29]]},"reference":[{"key":"6431_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(01)01070-1","volume":"112","author":"M Koreny","year":"2002","unstructured":"Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, Siostrzonek P: Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction.\n                           Am J Med 2002, 112: 115-119. 10.1016\/S0002-9343(01)01070-1","journal-title":"Am J Med"},{"key":"6431_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jama.285.2.190","volume":"285","author":"JS Hochmann","year":"2001","unstructured":"Hochmann JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, Boland J, Sanborn T, Buller CE, Modur S, Forman R, Desvigne-Nickens P, Jacobs AK, Slater JN, LeJemtel TH, SHOCK Investigators: Should we emergently revascularize occluded coronaries for cardiogenic shock: one-year survival following early revascularization for cardiogenic shock.\n                           JAMA 2001, 285: 190-192. 10.1001\/jama.285.2.190","journal-title":"JAMA"},{"key":"6431_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/00003246-199407000-00018","volume":"22","author":"J Bold","year":"1994","unstructured":"Bold J, Menges T, Wollbr\u00fcck M, Sonneborn S, Hempelmann G: Continuous hemofiltration and platelet function in critically ill patients.\n                           Crit Care Med 1994, 22: 1155-1160.","journal-title":"Crit Care Med"},{"key":"6431_CR4","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/039139880302601006","volume":"26","author":"J Mulder","year":"2003","unstructured":"Mulder J, Tan HK, Bellomo R, Silvester W: Platelet loss across hemofilter during continuous hemofiltration.\n                           Int J Artif Organs 2003, 26: 906-912.","journal-title":"Int J Artif Organs"},{"key":"6431_CR5","first-page":"130","volume":"4","author":"M Notohamiprodjo","year":"1986","unstructured":"Notohamiprodjo M, Andrassy K, Bommer J, Ritz E: Dialysis membranes and coagulation system.\n                           Blood 1986, 4: 130-141.","journal-title":"Blood"},{"key":"6431_CR6","first-page":"281","volume":"40","author":"LE Lins","year":"1993","unstructured":"Lins LE, Boberg U, Jacobson SH, Kjellstrand C, Ljungberg B, Skroder R: The influence of dialyzer geometry on blood coagulation and biocompatibility.\n                           Clin Nephrol 1993, 40: 281-285.","journal-title":"Clin Nephrol"},{"key":"6431_CR7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0038-1649615","volume":"70","author":"P Spangenberg","year":"1993","unstructured":"Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B: The platelet glycoprotein IIb-IIIa complex is involved in the adhesion of activated platelets to leukocytes.\n                           Thromb Haemost 1993, 70: 514-521.","journal-title":"Thromb Haemost"},{"key":"6431_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1525-1594.1999.06289.x","volume":"23","author":"MP Gawaz","year":"1999","unstructured":"Gawaz MP, Mujais SK, Schmidt B, Blumenstein M, Gurland HJ: Platelet-leukocyte aggregates during hemodialysis: effect of membrane type.\n                           Artif Organs 1999, 23: 29-36. 10.1046\/j.1525-1594.1999.06289.x","journal-title":"Artif Organs"},{"key":"6431_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000054726","volume":"90","author":"K Kawabata","year":"2002","unstructured":"Kawabata K, Nakai S, Miwa M, Sugiura T, Otsuaka Y, Shinzato T, Hiki Y, Tomimatsu I, Ushida Y, Hosono F, Maeda K: Platelet GP IIb\/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis.\n                           Nephron 2002, 90: 391-400. 10.1159\/000054726","journal-title":"Nephron"},{"key":"6431_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ki.1994.299","volume":"46","author":"MP Gawaz","year":"1994","unstructured":"Gawaz MP, Mujais SK, Schmidt B, Burland HJ: Platelet-leukocyte aggregation during hemodialysis.\n                           Kidney Int 1994, 46: 489-495. 10.1038\/ki.1994.299","journal-title":"Kidney Int"},{"key":"6431_CR11","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","author":"The PRISM-Plus Investigators","year":"1998","unstructured":"The PRISM-Plus Investigators: Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.\n                           N Engl J Med 1998, 338: 1488-1497. 10.1056\/NEJM199805213382102","journal-title":"N Engl J Med"},{"key":"6431_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0022-5223(97)70414-8","volume":"113","author":"Y Hiramatsu","year":"1997","unstructured":"Hiramatsu Y, Gikakis N, Anderson HL III, Gorman JH III, Marcinkiewicz C, Gould RJ, Niewiarowski S, Edmunds LH Jr: Tirofiban provides \"platelet anaesthesia\" during cardiopulmonary bypass in baboons.\n                           J Thorac Cardiovasc Surg 1997, 113: 182-193. 10.1016\/S0022-5223(97)70414-8","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6431_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00000542-200102000-00013","volume":"94","author":"A Koster","year":"2001","unstructured":"Koster A, Kukucka M, Bach F, Meyer O, Fischer T, Mertzlufft F, Loebe M, Hetzer R, Kuppe H: Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb\/IIIa antagonist tirofiban.\n                           Anesthesiology 2001, 94: 245-251. 10.1097\/00000542-200102000-00013","journal-title":"Anesthesiology"},{"key":"6431_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-2005-872952","volume":"54","author":"A Straub","year":"2006","unstructured":"Straub A, Azevedo R, Beierlein W, Wendel HP, Dietz K, Ziemer G: Tirofiban (Aggrastat\n                           \n                              \u00ae\n                           \n                           ) protects platelets and decrease platelet-granulocyte binding in an extracorporeal circulation model.\n                           J Thorac Cardiovasc Surg 2006, 54: 162-167. 10.1055\/s-2005-872952","journal-title":"J Thorac Cardiovasc Surg"},{"key":"6431_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-131-1-199907060-00010","volume":"131","author":"SM Hollenberg","year":"1999","unstructured":"Hollenberg SM, Kavinsky CJ, Parrillo JE: Cardiogenic shock.\n                           Ann Intern Med 1999, 131: 47-59.","journal-title":"Ann Intern Med"},{"key":"6431_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/0885066607299510","volume":"22","author":"R Venkataraman","year":"2007","unstructured":"Venkataraman R, Kellum JA: Defining acute renal failure: the RIFLE criteria.\n                           J Intensive Care Med 2007, 22: 187-193. 10.1177\/0885066607299510","journal-title":"J Intensive Care Med"},{"key":"6431_CR17","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","volume":"33","author":"S Uchino","year":"2007","unstructured":"Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA: Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.\n                           Intensive Care Med 2007, 33: 1563-1570. 10.1007\/s00134-007-0754-4","journal-title":"Intensive Care Med"},{"key":"6431_CR18","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1055\/s-2006-956275","volume":"131","author":"A Greinacher","year":"2006","unstructured":"Greinacher A, Kiefel V, Kl\u00fcter H, Kroll H, P\u00f6tzsch B, Riess H: Recommendations on platelet transfusion by the Joint Working Party of the German Society of Transfusion Medicine (DGTI), Thrombosis and Haemostasis Research (GTH), and Haemotology and Oncology (DGHO).\n                           Dtsch Med Wochenschr 2006, 131: 2675-2679. 10.1055\/s-2006-956275","journal-title":"Dtsch Med Wochenschr"},{"key":"6431_CR19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V34.2.204.204","volume":"34","author":"CH Mielke","year":"1969","unstructured":"Mielke CH, Kaneshiro MM, Maher IA: The standardised normal Ivy Bleeding Time and its prolongation by aspirin.\n                           Blood 1969, 34: 204-215.","journal-title":"Blood"},{"key":"6431_CR20","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1182\/blood.V87.12.4925.bloodjournal87124925","volume":"87","author":"AD Michelson","year":"1996","unstructured":"Michelson AD: Flow cytometry: a clinical test of platelet function.\n                           Blood 1996, 87: 4925-4936.","journal-title":"Blood"},{"key":"6431_CR21","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1016\/S0021-9258(17)39154-8","volume":"260","author":"SJ Shattil","year":"1985","unstructured":"Shattil SJ, Hoxie JA, Cunningham M, Brass L: Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation.\n                           J Biol Chem 1985, 260: 11107-11114.","journal-title":"J Biol Chem"},{"key":"6431_CR22","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.4049\/jimmunol.155.4.2109","volume":"155","author":"MR Elstad","year":"1995","unstructured":"Elstad MR, La Pine TR, Cowley FS, McEver RP, McIntyre TM, Prescott SM, Zimmerman GA: P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes.\n                           J Immunol 1995, 155: 2109-2122.","journal-title":"J Immunol"},{"key":"6431_CR23","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI118575","volume":"97","author":"AS Weyrich","year":"1996","unstructured":"Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA: Activated platelets signal chemokine synthesis by human monocytes.\n                           J Clin Invest 1996, 97: 1525-1534. 10.1172\/JCI118575","journal-title":"J Clin Invest"},{"key":"6431_CR24","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S0735-1097(99)00350-2","volume":"34","author":"FJ Neumann","year":"1999","unstructured":"Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Sch\u00f6mig A: Effect of glycoprotein IIb\/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin MAC-1 in acute myocardial infarction.\n                           J Am Coll Cardiol 1999, 34: 1420-1426. 10.1016\/S0735-1097(99)00350-2","journal-title":"J Am Coll Cardiol"},{"key":"6431_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/01.ATV.0000106320.40933.E5","volume":"24","author":"P da Costa Martins","year":"2004","unstructured":"da Costa Martins P, Berk N, Ulfman LH, Koenderman L, Hordijk PL, Zwaginga JJ: Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation.\n                           Arterioscler Thromb Vasc Biol 2004, 24: 193-199. 10.1161\/01.ATV.0000106320.40933.E5","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6431_CR26","first-page":"566","volume":"16","author":"S Morabito","year":"2003","unstructured":"Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A: Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.\n                           J Nephrol 2003, 16: 566-571.","journal-title":"J Nephrol"},{"key":"6431_CR27","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1213\/01.ANE.0000131509.94879.FB","volume":"99","author":"A Koster","year":"2004","unstructured":"Koster A, Chew D, Merkle F, Gruendel M, Jurmann M, Kuppe H, Oertel R: Extracorporeal elimination of large concentrations of tirofiban by zero-balanced ultrafilration during cardiopulmonary bypass: an in vitro investigation.\n                           Anesth Analg 2004, 99: 989-992. 10.1213\/01.ANE.0000131509.94879.FB","journal-title":"Anesth Analg"},{"key":"6431_CR28","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1161\/01.CIR.103.21.2572","volume":"103","author":"SR Steinhubl","year":"2001","unstructured":"Steinhubl SR, Tallex JD, Braden GA, Tcheng JE, Casterella PJ, Moliterno DJ, Navetta FI, Berger PB, Popma JJ, Dangas G, Gallo R, Sane DC, Saucedo JF, Jia GJ, Lincoff M, Theroux P, Holmes DR, Teirstein PS, Kereiakes DJ: Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention. Results of the GOLD (AU-Assessing Ultegra) multicenter study.\n                           Circulation 2001, 103: 2572-2578.","journal-title":"Circulation"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc6998.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc6998\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc6998.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:18:47Z","timestamp":1728303527000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc6998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,29]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2008,8]]}},"alternative-id":["6431"],"URL":"https:\/\/doi.org\/10.1186\/cc6998","relation":{},"ISSN":["1364-8535"],"issn-type":[{"type":"electronic","value":"1364-8535"}],"subject":[],"published":{"date-parts":[[2008,8,29]]},"assertion":[{"value":"8 April 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R111"}}